Managing Adverse Events Associated with Vismodegib in the Treatment of Basal Cell Carcinoma

The document discussed managing adverse events associated with vismodegib, a treatment for basal cell carcinoma. It highlighted the importance of monitoring and addressing side effects to improve patient outcomes. The paper emphasized strategies for mitigating common adverse events such as muscle spasms, alopecia, and dysgeusia, which are critical for maintaining patient adherence to the treatment regimen. The study underscored the need for a multidisciplinary approach to manage these side effects effectively.